US2007275995A1PendingUtilityA1
Thiobenzimidazole derivatives
Est. expiryJul 15, 2018(expired)· nominal 20-yr term from priority
A61P 9/00A61P 9/10A61P 37/08A61P 29/00A61P 27/14A61P 19/00A61P 19/02A61P 11/06C07D 401/12C07D 413/12C07D 471/04C07D 235/28C07D 417/12C07D 405/12C07D 409/12C07D 403/06C07D 409/06
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention is a thiobenzimidazole derivative represented by the following formula (1) or a medically acceptable salt thereof wherein said thiobenzimidazole derivative and a medically acceptable salt thereof have a potent activity of inhibiting human chymase. Thus, they are potential preventive and/or therapeutic agents clinically applicable to various diseases in which human chymase is involved.
Claims
exact text as granted — not AI-modified1 . A method for inhibiting human chymase by administering to a human subject an effective amount of a pharmaceutical composition comprising a thiobenzimidazole compound represented by the following formula (1) or a medically acceptable salt thereof as the active ingredient and a pharmaceutically acceptable carrier:
wherein,
R 1 and R 2 simultaneously or respectively independently represent a hydrogen atom, halogen atom, trifluoromethyl group, cyano group, hydroxyl group, methyl group, ethyl group, (n- or i-)propyl group, (n-, i-, s- or t-)butyl group, methoxy group, ethoxy group, (n- or i-)propyloxy group, (n-, i-, s- or t-)butyloxy group, or R 1 and R 2 together represent —O—CH 2 —O—, —O—CH 2 —CH 2 —O— or —CH 2 —CH 2 —CH 2 — in this case, the carbon atoms may be substituted with one or a plurality of methyl groups, ethyl groups, (n- or i-)propyl groups or (n-, i-, s- or t-)butyl groups;
A represents a single bond, a substituted or non-substituted methylene group, ethylene group, (n- or i-)propylene group or (n-, i- or t-)butylene group, substituted or non-substituted phenylene group, indenylene group or naphthylene group, substituted or non-substituted pyridylene group, furanylene group, thiophenylene group, pyrimidylene group, benzophenylene group, benzimidazolene group, quinolylene group, indolene group or benzothiazolene group and substitution groups here are represented by a halogen atom, OH, NO 2 , CN, methyl group, ethyl group (n- or i-)propyl group, (n-, i-, s- or t-)butyl group, methoxy group, ethoxy group, (n- or i-)propyloxy group, (n-, i-, s- or t-)butyloxy group, in this case, substitution groups may be acetal-bonded at mutually adjacent sites, methylthio group, ethylthio group, (n- or i-)propylthio group, (n-, i-, s- or t-)butylthio, methylsulfonyl group, ethylsulfonyl group, (n- or i-)propylsulfonyl group, (n-, i-, s- or t-)butylsulfonyl group, acetyl group, ethylcarbonyl group, (n- or i-)propylcarbonyl group, acetylamino group, ethylcarbonylamino group, (n- or i-) propylcarbonylamino group, (n-, i-, s- or t-)butylcarbonylamino group, trifluoromethyl group or trifluoromethoxy group, and one or a plurality of these may be respectively and independently substituted at an arbitrary location of a ring or alkylene group;
E represents COOR 3 , SO 3 R 3 , CONHR 3 , SO 2 NHR 3 , a tetrazole group, 5-oxo-1,2,4-oxadiazole group or 5-oxo-1,2,4-thiadiazole group wherein, R 3 represents a hydrogen atom, methyl group, ethyl group, (n- or i-)propyl group or (n-, i-, s- or t-)butyl group;
G represents a substituted or non-substituted methylene group, ethylene group, (n- or i-) propylene group or (n-, i- or t-)butylene group, and one or a plurality of O, S, SO 2 or NR 3 may be intermediately contained therein, wherein R 3 is the same as previously defined, and substitution groups here are represented by a halogen atom, OH, NO 2 , CN, methyl group, ethyl group, (n- or i-)propyl group, (n-, i-, s- or t-)butyl group, methoxy group, ethoxy group, (n- or i-)propyloxy group, (n-, i-, s- or t-)butyloxy group, trifluoromethyl group, trifluoromethoxy group or oxo group;
m represents an integer of 0-2;
when m is 0 and A is a substituted or non-substituted methylene group, ethylene group, (n- or i-)propylene group or (n-, i- or t-)butylene group, J represents a substituted or non-substituted (n- or i-)propyl group, (n-, i-, s- or t-)butyl group, (n-, i-, ne- or t-)pentyl group, cyclohexyl group, indenyl group, furanyl group, thiophenyl group, pyrimidyl group, benzofuranyl group, benzimidazolyl group, quinolyl group, isoquinolyl group, quinoxalyl group, benzooxadiazolyl group, benzothiadiazolyl group, indolyl group, N-methylindolyl group, benzothiazolyl group, benzothiophenyl group or benzoisooxazolyl group substituted naphthyl group,
when m is 0 and A is a substituted or non-substituted phenylene group, indenylene group or naphthylene group, or a substituted or non-substituted pyridylene group, furanylene group, thiophenylene group, pyrimidylene group, benzophenylene group, benzimidazolene group, quinolylene group, indolene group or benzothiazolene group, J represents a substituted or non-substituted cyclohexyl group, phenyl group, indenyl group, naphthyl group, furanyl group, thiophenyl group, pyrimidyl group, benzofuranyl group, benzimidazolyl group, quinolyl group, isoquinolyl group, quinoxalyl group, benzooxadiazolyl group, benzothiadiazolyl group, indolyl group, N-methylindolyl group, benzothiazolyl group, benzothiophenyl group or benzoisooxazolyl group;
when m is 0 and A is a single bond or when m is 1 or 2, J represents a substituted or non-substituted-cyclohexyl group, phenyl group, indenyl group, naphthyl group, furanyl group, thiophenyl group, pyrimidyl group, benzofuranyl group, benzimidazolyl group, quinolyl group, isoquinolyl group, quinoxalyl group, benzooxadiazolyl group, benzothiadiazolyl group, indolyl group, N-methylindolyl group, benzothiazolyl group, benzothiophenyl group or benzoisooxazolyl group; substitution groups here are represented by a halogen atom, OH, NO 2 , CN, methyl group, ethyl group (n- or i-)propyl group, (n-, i-, s- or t-)butyl group, methoxy group, ethoxy group, (n- or i-)propyloxy group, (n-, i-, s- or t-)butyloxy group, methylthio group, ethylthio group, (n- or i-)propylthio group, (n-, i-, s- or t-)butylthio group, methylsulfonyl group, ethylsulfonyl group, (n- or i-)propylsulfonyl group, (n-, i-, s- or t-)butylsulfonyl group, acetyl group, ethylcarbonyl group, (n- or i-)propylcarbonyl group, acetylamino group, ethylcarbonylamino group, (n- or i-) propylcarbonylamino group, (n-, i-, s- or t-)butylcarbonylamino group, trifluoromethyl group or trifluoromethoxy group, and one or a plurality of these may be respectively and independently substituted at an arbitrary location of a ring or alkyl group; and,
X represents CH or a nitrogen atom.
2 . The method of claim 1 , wherein in the formula (1), m is 0, A is a substituted or non-substituted methylene group, ethylene group, (n- or i-)propylene group or (n-, i- or t-)butylene group, and J is a substituted or non-substituted furanyl group, thiophenyl group, pyrimidyl group, benzofuranyl group, benzimidazolyl group, quinolyl group, isoquinolyl group, quinoxalyl group, benzooxadiazolyl group, benzothiadiazolyl group, indolyl group, N-methylindolyl group, benzothiazolyl group, benzothiophenyl group or benzoisooxazolyl group.
3 . A method for treating an allergic disease, bronchial asthma, cardiovascular disease selected from the group consisting of sclerosing vascular lesions, peripheral circulation disorders, renal insufficiency and cardiac insufficiency, and bone/cartilage metabolic diseases selected from the group consisting of rheumatoid arthritis and osteoarthritis by administering to a human subject an effective amount of a pharmaceutical composition comprising a thiobenzimidazole compound of the following formula (1) or a medically acceptable salt thereof as the active ingredient:
wherein,
R 1 and R 2 simultaneously or respectively independently represent a hydrogen atom, halogen atom, trifluoromethyl group, cyano group, hydroxyl group, methyl group, ethyl group, (n- or i-)propyl group, (n-, i-, s- or t-)butyl group, methoxy group, ethoxy group, (n- or i-)propyloxy group, (n-, i-, s- or t-)butyloxy group, or R 1 and R 2 together represent —O—CH 2 —O—, —O—CH 2 —CH 2 —O— or —CH 2 —CH 2 —CH 2 — in this case, the carbon atoms may be substituted with one or a plurality of methyl groups, ethyl groups, (n- or i-)propyl groups or (n-, i-, s- or t-)butyl groups;
A represents a single bond, a substituted or non-substituted methylene group, ethylene group, (n- or i-)propylene group or (n-, i- or t-)butylene group, substituted or non-substituted phenylene group, indenylene group or naphthylene group, substituted or non-substituted pyridylene group, furanylene group, thiophenylene group, pyrimidylene group, benzophenylene group, benzimidazolene group, quinolylene group, indolene group or benzothiazolene group and substitution groups here are represented by a halogen atom, OH, NO 2 , CN, methyl group, ethyl group (n- or i-)propyl group, (n-, i-, s- or t-)butyl group, methoxy group, ethoxy group, (n- or i-)propyloxy group, (n-, i-, s- or t-)butyloxy group, in this case, substitution groups may be acetal-bonded at mutually adjacent sites, methylthio group, ethylthio group, (n- or i-)propylthio group, (n-, i-, s- or t-)butylthio, methylsulfonyl group, ethylsulfonyl group, (n- or i-)propylsulfonyl group, (n-, i-, s- or t-)butylsulfonyl group, acetyl group, ethylcarbonyl group, (n- or i-)propylcarbonyl group, acetylamino group, ethylcarbonylamino group, (n- or i-) propylcarbonylamino group, (n-, i-, s- or t-)butylcarbonylamino group, trifluoromethyl group or trifluoromethoxy group, and one or a plurality of these may be respectively and independently substituted at an arbitrary location of a ring or alkylene group;
E represents COOR 3 , SO 3 R 3 , CONHR 3 , SO 2 NHR 3 , a tetrazole group, 5-oxo-1,2,4-oxadiazole group or 5-oxo-1,2,4-thiadiazole group wherein, R 3 represents a hydrogen atom, methyl group, ethyl group, (n- or i-)propyl group or (n-, i-, s- or t-)butyl group;
G represents a substituted or non-substituted methylene group, ethylene group, (n- or i-) propylene group or (n-, i- or t-)butylene group, and one or a plurality of O, S, SO 2 or NR 3 may be intermediately contained therein, wherein R 3 is the same as previously defined, and substitution groups here are represented by a halogen atom, OH, NO 2 , CN, methyl group, ethyl group, (n- or i-)propyl group, (n-, i-, s- or t-)butyl group, methoxy group, ethoxy group, (n- or i-)propyloxy group, (n-, i-, s- or t-)butyloxy group, trifluoromethyl group, trifluoromethoxy group or oxo group;
m represents an integer of 0-2;
when m is 0 and A is a substituted or non-substituted methylene group, ethylene group, (n- or i-)propylene group or (n-, i- or t-)butylene group, J represents a substituted or non-substituted (n- or i-)propyl group, (n-, i-, s- or t-)butyl group, (n-, i-, ne- or t-)pentyl group, cyclohexyl group, indenyl group, furanyl group, thiophenyl group, pyrimidyl group, benzofuranyl group, benzimidazolyl group, quinolyl group, isoquinolyl group, quinoxalyl group, benzooxadiazolyl group, benzothiadiazolyl group, indolyl group, N-methylindolyl group, benzothiazolyl group, benzothiophenyl group or benzoisooxazolyl group substituted naphthyl group,
when m is 0 and A is a substituted or non-substituted phenylene group, indenylene group or naphthylene group, or a substituted or non-substituted pyridylene group, furanylene group, thiophenylene group, pyrimidylene group, benzophenylene group, benzimidazolene group, quinolylene group, indolene group or benzothiazolene group, J represents a substituted or non-substituted cyclohexyl group, phenyl group, indenyl group, naphthyl group, furanyl group, thiophenyl group, pyrimidyl group, benzofuranyl group, benzimidazolyl group, quinolyl group, isoquinolyl group, quinoxalyl group, benzooxadiazolyl group, benzothiadiazolyl group, indolyl group, N-methylindolyl group, benzothiazolyl group, benzothiophenyl group or benzoisooxazolyl group;
when m is 0 and A is a single bond or when m is 1 or 2, J represents a substituted or non-substituted-cyclohexyl group, phenyl group, indenyl group, naphthyl group, furanyl group, thiophenyl group, pyrimidyl group, benzofuranyl group, benzimidazolyl group, quinolyl group, isoquinolyl group, quinoxalyl group, benzooxadiazolyl group, benzothiadiazolyl group, indolyl group, N-methylindolyl group, benzothiazolyl group, benzothiophenyl group or benzoisooxazolyl group; substitution groups here are represented by a halogen atom, OH, NO 2 , CN, methyl group, ethyl group (n- or i-)propyl group, (n-, i-, s- or t-)butyl group, methoxy group, ethoxy group, (n- or i-)propyloxy group, (n-, i-, s- or t-)butyloxy group, methylthio group, ethylthio group, (n- or i-)propylthio group, (n-, i-, s- or t-)butylthio group, methylsulfonyl group, ethylsulfonyl group, (n- or i-)propylsulfonyl group, (n-, i-, s- or t-)butylsulfonyl group, acetyl group, ethylcarbonyl group, (n- or i-)propylcarbonyl group, acetylamino group, ethylcarbonylamino group, (n- or i-) propylcarbonylamino group, (n-, i-, s- or t-)butylcarbonylamino group, trifluoromethyl group or trifluoromethoxy group, and one or a plurality of these may be respectively and independently substituted at an arbitrary location of a ring or alkyl group; and,
X represents CH or a nitrogen atom.
4 . the method of claim 34 , wherein in the formula (1), m is 0, A is a substituted or non-substituted methylene group, ethylene group, (n- or i-)propylene group or (n-, i- or t-)butylene group, and J is a substituted or non-substituted furanyl group, thiophenyl group, pyrimidyl group, benzofuranyl group, benzimidazolyl group, quinolyl group, isoquinolyl group, quinoxalyl group, benzooxadiazolyl group, benzothiadiazolyl group, indolyl group, N-methylindolyl group, benzothiazolyl group, benzothiophenyl group or benzoisooxazolyl group.Join the waitlist — get patent alerts
Track US2007275995A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.